These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 28740772)
1. Relationship between Keloid Formation and YAP/TAZ Signaling. Aramaki-Hattori N; Okabe K; Hamada M; Takato T; Kishi K Plast Reconstr Surg Glob Open; 2017 Jun; 5(6):e1357. PubMed ID: 28740772 [TBL] [Abstract][Full Text] [Related]
2. Targeted inhibition of YAP/TAZ alters the biological behaviours of keloid fibroblasts. Gao N; Lu L; Ma X; Liu Z; Yang S; Han G Exp Dermatol; 2022 Mar; 31(3):320-329. PubMed ID: 34623712 [TBL] [Abstract][Full Text] [Related]
3. YAP/TAZ: a promising target for squamous cell carcinoma treatment. Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073 [TBL] [Abstract][Full Text] [Related]
4. [Role of Hippo-YAP/TAZ signaling pathway in mechanotransduction.]. Ishihara E; Nishina H Clin Calcium; 2016; 26(12):1751-1756. PubMed ID: 27885187 [TBL] [Abstract][Full Text] [Related]
5. YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer. Noguchi S; Saito A; Nagase T Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463366 [TBL] [Abstract][Full Text] [Related]
6. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer. Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404 [TBL] [Abstract][Full Text] [Related]
7. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy. Juan WC; Hong W Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805 [TBL] [Abstract][Full Text] [Related]
8. The regulation of yes-associated protein/transcriptional coactivator with PDZ-binding motif and their roles in vascular endothelium. Zhang W; Li QQ; Gao HY; Wang YC; Cheng M; Wang YX Front Cardiovasc Med; 2022; 9():925254. PubMed ID: 35935626 [TBL] [Abstract][Full Text] [Related]
9. Activation of Yes-Associated Protein/PDZ-Binding Motif Pathway Contributes to Endothelial Dysfunction and Vascular Inflammation in AngiotensinII Hypertension. Xu Q; Zhuo K; Cai R; Su X; Zhang L; Liu Y; Zhu L; Ren F; Zhou MS Front Physiol; 2021; 12():732084. PubMed ID: 34650444 [TBL] [Abstract][Full Text] [Related]
10. A spatial model of YAP/TAZ signaling reveals how stiffness, dimensionality, and shape contribute to emergent outcomes. Scott KE; Fraley SI; Rangamani P Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33990464 [TBL] [Abstract][Full Text] [Related]
11. Expression and localization of Yap and Taz during development of the mandibular first molar in rats. Zhang B; Sun BY; Ji YW; Zhang YP; Wang XX; Xu X; Wen Y Biotech Histochem; 2017; 92(3):212-221. PubMed ID: 28402144 [TBL] [Abstract][Full Text] [Related]
12. Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow. Wang L; Luo JY; Li B; Tian XY; Chen LJ; Huang Y; Liu J; Deng D; Lau CW; Wan S; Ai D; Mak KK; Tong KK; Kwan KM; Wang N; Chiu JJ; Zhu Y; Huang Y Nature; 2016 Dec; 540(7634):579-582. PubMed ID: 27926730 [TBL] [Abstract][Full Text] [Related]
13. miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer. Zhu B; V M; Finch-Edmondson M; Lee Y; Wan Y; Sudol M; DasGupta R Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670427 [TBL] [Abstract][Full Text] [Related]
14. The Hippo-YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After Injury. Deng F; Wu Z; Zou F; Wang S; Wang X Front Cell Dev Biol; 2022; 10():894737. PubMed ID: 35927987 [TBL] [Abstract][Full Text] [Related]
15. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis. Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139 [TBL] [Abstract][Full Text] [Related]
16. The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises. Ortega Á; Vera I; Diaz MP; Navarro C; Rojas M; Torres W; Parra H; Salazar J; De Sanctis JB; Bermúdez V Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008857 [TBL] [Abstract][Full Text] [Related]
17. Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications. Sun T; Chi JT Genes Dis; 2021 May; 8(3):241-249. PubMed ID: 33997171 [TBL] [Abstract][Full Text] [Related]
18. Evolution of mechanotransduction via YAP/TAZ in animal epithelia. Elbediwy A; Thompson BJ Curr Opin Cell Biol; 2018 Apr; 51():117-123. PubMed ID: 29477107 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of a component of the Hippo pathway, TAZ, in human uterine endometrioid adenocarcinoma. Zhan M; Ikeda JI; Wada N; Hori Y; Nojima S; Tahara SI; Ueda Y; Yoshino K; Kimura T; Morii E Oncol Lett; 2016 Jun; 11(6):3611-3616. PubMed ID: 27284362 [TBL] [Abstract][Full Text] [Related]
20. A Computational Model of YAP/TAZ Mechanosensing. Sun M; Spill F; Zaman MH Biophys J; 2016 Jun; 110(11):2540-2550. PubMed ID: 27276271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]